Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 29, 2022
Oct. 30, 2021
Oct. 29, 2022
Oct. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Net sales $ 123,264 $ 130,681 $ 411,042 $ 357,325
Cost of sales 71,754 76,260 249,782 208,911
Gross profit 51,510 54,421 161,260 148,414
Operating expense:        
Distribution and selling 35,261 39,302 115,150 108,907
General and administrative 21,185 10,746 44,818 24,569
Depreciation and amortization 8,778 9,741 27,421 24,727
Restructuring costs 1,551 634 4,490 634
Total operating expense 66,775 60,423 191,879 158,837
Operating loss (15,265) (6,002) (30,619) (10,423)
Other income (expense):        
Interest income and other 20 85 230 124
Interest expense (6,038) (3,551) (15,932) (6,245)
Change in fair value of contract liability, net     1,937  
Loss on divestiture     (985)  
Loss on debt extinguishment   (9) (884) (663)
Total other expense, net (6,018) (3,475) (15,634) (6,784)
Loss before income taxes (21,283) (9,477) (46,253) (17,207)
Income tax provision (15) (15) (47) (45)
Net loss (21,298) (9,492) (46,300) (17,252)
Less: Net loss attributable to non-controlling interest     (415) (282)
Net loss attributable to shareholders $ (21,298) $ (9,492) $ (45,885) $ (16,970)
Net loss per common share $ (0.72) $ (0.44) $ (1.77) $ (0.91)
Net loss per common share - assuming dilution $ (0.72) $ (0.44) $ (1.77) $ (0.91)
Weighted average number of common shares outstanding:        
Basic 29,415,680 21,503,340 25,932,294 18,710,658
Diluted 29,415,680 21,503,340 25,932,294 18,710,658